Conference announcement: Genome-based approaches to Drug Discovery

Cambridge Healthtech Institute inquiries at healthtech.com
Thu Nov 16 13:41:20 EST 1995


Cambridge Healthtech Institute, producer of meetings of interest to
biomedical professionals, is announcing their upcoming meeting,
"Strategies for Identification of Novel Targets for Drug Discovery,"
to be held  January 8-9, 1996 at the Hyatt LaJolla in San Diego,
California.

Topic Description:
Almost all modern drug discovery efforts, whether based on screening,
structure-based design or other approaches, depend first on the
selection of a biomolecular target.  The development of breakthrough
drugs, for indications lacking any current therapy, is even more
dependent on finding novel targets.  Receptors and ligands, enzymes,
genes and other biomolecules, from both humans or infectious
organisms, can be appropriate targets.  Confirmation of a new target
as suitable requires characterization of its functionality, and thus
its biological role in the disease process.  This program examines in
detail a number of innovative strategies available for this purpose,
including the rapidly expanding use of genome-based approaches.

Co-sponsoring Journals: 
Perspectives in Drug Discovery & Design (PD3)
Drug Discovery Today

Speakers:
Dr. Derk Bergsma, SmithKline Beecham Pharmaceuticals
Dr. Richard A. Bond, University of Houston
Dr. Tauseef R. Butt, SmithKline Beecham Pharmaceuticals
Dr. Benjamin P. Chen, SyStemix Corp.
Dr. Patrick J. Dillon, Human Genome Sciences, Inc.
Dr. Giora Z. Feuerstein, SmithKline Beecham Pharmaceuticals
Dr. Mark C. Hanks, Procter & Gamble Pharmaceuticals 
Dr. Michael M. Harpold, The Salk Institute Biotechnology/ Industrial
Associates, Inc.
Dr. Steven J. Henriksen, The Scripps Research Institute
Dr. Kenneth G. Krul, The Panda Group, Inc.
Dr. Michael N. Liebman, Vysis, Inc.
Dr. Sergio Lira, Bristol-Myers Squibb Pharmaceutical Research
Institute
Dr. Randal W. Scott, Incyte Pharmaceuticals, Inc.
Dr. Bob Shopes, Tera Biotechnology Corp.
Dr. Francis P. Tally, Cubist Pharmaceuticals, Inc.
Prof. Marc Vasseur, Genset
Dr. Gerald F. Vovis, Genome Therapeutics Corporation
Dr. Mickey Williams, Genentech, Inc.
Dr. John R. Yates, University of Washington School of Medicine

Advance registration deadline: December 8, 1995.  For more
information, contact Cambridge Healthtech Institute.

______________________________
Cambridge Healthtech Institute      
1037 Chestnut Street
Newton Upper Falls, MA  02164
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
tel: 617.630.1300
fax: 617.630.1325
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
inquiries at healthtech.com
World Wide Web http://www.healthtech.com/conferences




More information about the Methods mailing list